Docarpamine
Alternative Names: TA 870; TA 8704; TanadopaLatest Information Update: 01 Oct 2007
At a glance
- Originator Tanabe Seiyaku
- Developer Mitsubishi Tanabe Pharma Corporation; Novartis
- Class Cardiotonics; Catecholamines; Small molecules
- Mechanism of Action Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Heart failure
Most Recent Events
- 01 Oct 2007 Mitsubishi Pharma Corporation has merged with Tanabe Seiyaku to form Mitsubishi Tanabe Pharma Corporation
- 26 Jan 1995 Launched for Heart failure in Japan (Unknown route)